| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.1M | -32.1% |
| R&D Expense | $117.8M | +24.5% |
| SG&A Expense | $42.8M | +28.7% |
| Operating Income | -$129.5M | -57.7% |
| Income Tax | $0 | — |
| Net Income | -$128.2M | -52.8% |
| EPS (Basic) | -$2.62 | -44.0% |
| EPS (Diluted) | -$2.62 | -44.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.8M | -60.9% |
| Accounts Receivable | $1.5M | -74.2% |
| Current Assets | $287.6M | -11.7% |
| Total Assets | $430.8M | -15.0% |
| Current Liabilities | $44.5M | -13.1% |
| Long-term Debt | $11.5M | +6.6% |
| Total Liabilities | $141.6M | +20.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$105.9M | -21.8% |
| Capital Expenditures | $5.5M | +330.4% |
| Investing Cash Flow | $58.4M | +130.9% |
| Financing Cash Flow | $1.1M | -99.3% |
| Free Cash Flow | -$111.4M | -26.3% |
| Stockholders' Equity |
| $289.2M |
| -25.8% |